Covington advised Insmed Incorporated on the deal while Fenwick represented Pharmakon. Walder Wyss advised the funds managed by Pharmakon Advisors, LP, BioPharma Credit and OrbiMed. Akin...
Insmed Incorporated’s $775 Million Financing
BioPharma Credit’s $300 Million Loan to LumiraDx
Akin Gump Strauss Hauer & Feld LLP advised BioPharma Credit PLC on the deal, while Dechert LLP advised Pharmakon Advisors LP. LumiraDx has secured new financing commitments...